SSO and cell-tolerance assays
In HeLa_Luc705 cells, EEE32 retained SSO-enhancing activity similar to EEE4 in the reported assay. Figure 3A: 1 µM SSO, EEE concentration series, 24-h EEE exposure.
WST-1 and LDH assays showed a more favourable profile than EEE4 at some tested doses/time points. This does not establish general safety.
Figure 3A and corresponding Results/Methods · Estupiñán et al., 2025 · DOI: 10.1016/j.omtn.2025.102522
Primary hepatocyte siRNA assay
Primary human hepatocytes: the paper reports siPPIB + EEE32 IC50 10 nM versus 9 nM for GalNAc-siPPIB, with 2 µM EEE32 in the main protocol. Similar estimates do not establish equivalence. EEE32 also enhanced GalNAc-siPPIB activity and siSOD1 knockdown.
siRNA sampling: Methods specify harvest 72 h after treatment start; the Figure 5 caption states 48 h. Both source statements are retained.
Figure 5A; Results, EEE32 as a multimodal oligonucleotide therapeutics enhancer · Estupiñán et al., 2025 · DOI: 10.1016/j.omtn.2025.102522
DC Chemicals supplies the compound only. Literature results apply to the cited cells, cargo and experimental conditions and do not guarantee performance in another experiment or delivery system.